LAZARD ASSET MANAGEMENT LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$86,000
+28.4%
3,061
+0.2%
0.00%
Q2 2022$67,000
-20.2%
3,054
+4.2%
0.00%
Q1 2022$84,000
+21.7%
2,930
+37.9%
0.00%
Q4 2021$69,000
-28.9%
2,125
+0.6%
0.00%
Q3 2021$97,000
-32.6%
2,113
-19.7%
0.00%
Q2 2021$144,000
+7100.0%
2,630
+5160.0%
0.00%
Q1 2021$2,0000.0%500.0%0.00%
Q4 2020$2,000
-98.4%
50
-97.9%
0.00%
Q2 2020$125,000
+71.2%
2,341
+12.7%
0.00%
Q1 2020$73,000
-88.9%
2,078
-85.5%
0.00%
-100.0%
Q4 2018$659,000
-40.2%
14,3000.0%0.00%
-50.0%
Q3 2018$1,102,000
-73.3%
14,300
-70.9%
0.00%
-71.4%
Q2 2018$4,134,000
+77.2%
49,087
+72.0%
0.01%
+75.0%
Q1 2018$2,333,000
+4.3%
28,532
-27.1%
0.00%0.0%
Q4 2017$2,237,000
-36.3%
39,136
-25.7%
0.00%
-33.3%
Q3 2017$3,514,000
+131.8%
52,659
+78.6%
0.01%
+100.0%
Q2 2017$1,516,00029,4800.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders